Hospital Acquired Disease Testing Market

Hospital Acquired Disease Testing Market - Trends
and Forecast till 2025
Hospital-acquired diseases are those infections that are acquired by the patient under medical
care. The most common type of hospital-acquired infections are urinary tract infection,
bloodstream infections, MRSA, pneumococcal infections, and gastrointestinal illnesses. An
increasing rate of morbidity related to hospital-acquired infections worldwide is the major driver
for the growth of hospital-acquired disease testing market. Devices employed in modern care
facilities, such as catheters and ventilators are also associated with the cause of these infections.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/992
Market Dynamics
According to World health organization (WHO), 2011, highest prevalence of hospital-acquired
infections occur in intensive care units, orthopedic, and acute surgical ward. According to an
article in Journal of Nursing & Health Sciences, 2016, the prevalence rate of hospital-acquired
diseases is approximately 5.1% to 11.6% in emerging economies. Around 1.7 million people are
affected by HAI in the U.S. itself accounting for 9.9 infections per 1000 patients a day. High
prevalence rate is the key factor propelling the growth of market in near future.
Urinary tract infection is the most common infection, owing to its high risk in the patients
indwelling with urinary catheter, which leads to increase chance of bacterial invasion from the
anus to the urinary tract and promotes colonization of bacteria.
The most common techniques used for diagnosis of the hospital-associated infections are solid
phase hybridization, PCR, and microarrays. Curetis Unyvero System, launched in 2012, a new
molecular device used for rapid detection microorganism and antibiotic resistance gene.
Antibiotic resistance is also the major concern factor associated with hospital-acquired Disease
testing.
Report includes chapters which deeply display the following deliverable about industry :
• Hospital Acquired Disease Testing Market Research Objective and Assumption
• Hospital Acquired Disease Testing Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Hospital Acquired Disease Testing Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Hospital Acquired Disease Testing Market, By Regions
• Hospital Acquired Disease Testing Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Hospital Acquired Disease Testing Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Hospital Acquired Disease Testing Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Hospital Acquired Disease Testing Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Antibodies resistance and extended hospitalization is expected to propel growth of hospital
acquired disease testing in the near future
High prevalence of nosocomial infections such as surgical wounds, urinary tract infections, and
lower respiratory tract infections in intensive care units, orthopedic, and acute surgical ward
fuels growth of hospital acquired disease testing market. The technique used for preventions,
diagnosis, and testing of hospital acquired diseases are microarray, PCR, and solid phase
hybridization. The urinary tract infections is most common in patients dwelling with urinary
catheter, as urethra is located close to the anus, which increases the changes of invasions of
bacteria from large intestine into the urinary tracts. Therefore, expenses and antibiotic
resistance increases with extended hospitalization, which in turn propels growth of hospital
acquired disease testing market.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/992
The key market players are Diatherix laboratories, Life technologies, Cantel Medical Corporation
Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid & others.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Hospital-acquired diseases are those infections that are acquired by the patient under medical care.

Download Report